Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients ; volume:15 ; number:1 ; day:10 ; month:10 ; year:2017 ; pages:1-18 ; date:12.2017
World journal of surgical oncology ; 15, Heft 1 (10.10.2017), 1-18, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Dhir, Mashaal
- Beteiligte Personen und Organisationen
-
Malhotra, Gautam K.
Sohal, Davendra P.S
Hein, Nicholas A.
Smith, Lynette M.
O’Reilly, Eileen M.
Bahary, Nathan
Are, Chandrakanth
SpringerLink (Online service)
- DOI
-
10.1186/s12957-017-1240-2
- URN
-
urn:nbn:de:1111-201711156169
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dhir, Mashaal
- Malhotra, Gautam K.
- Sohal, Davendra P.S
- Hein, Nicholas A.
- Smith, Lynette M.
- O’Reilly, Eileen M.
- Bahary, Nathan
- Are, Chandrakanth
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
5520
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
Models of pancreatic ductal adenocarcinoma
Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
5520 Nidda
TGL 5520
TGL 5520
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
5520
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
Models of pancreatic ductal adenocarcinoma
Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
5520 Nidda
TGL 5520
TGL 5520
Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
5520
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis
Models of pancreatic ductal adenocarcinoma
Effect and limitation of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma: consideration from a new perspective
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
5520 Nidda
TGL 5520